CEO: Leonard S. Schleifer

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Regeneron Pharmaceuticals Inc is an integrated biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.


Key numbers

Market Capitalization:42374656662
Shares Outstanding: 107947000
Float: 81698607
Next Earning Date:2020-02-11
TTm EPS: 19.7
TTm Dividend Rate:
200 days moving average:323.88
50 days moving average: 366.11
One day percent Change: -0.71



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,